VOGELBAUM MARTIN
Insider CIK 1237624 · ITEK Director · NRX Director · CARA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CARA Cara Therapeutics, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 390,000 | — | $0 | 390,000 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award | 2024-06-04 | 2024-06-06 | 301,295 | — | $0 | 411,007 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 89,923 | — | $0 | 89,923 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award | 2023-06-01 | 2023-06-05 | 64,724 | — | $0 | 109,712 | SEC↗ |
| CARA Cara Therapeutics, Inc. | S Sale | 2022-09-14 | 2022-09-16 | 10,800 | $10.28 | $111.0K | 44,988 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 33,993 | — | $0 | 33,993 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award | 2022-06-02 | 2022-06-06 | 23,752 | — | $0 | 43,912 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award | 2022-06-02 | 2022-06-06 | 11,876 | — | $0 | 55,788 | SEC↗ |
| CARA Cara Therapeutics, Inc. | S Sale | 2021-06-07 | 2021-06-07 | 8,640 | $13.05 | $112.8K | 20,160 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-07 | 21,600 | — | $0 | 21,600 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award | 2021-06-03 | 2021-06-07 | 14,400 | — | $0 | 28,800 | SEC↗ |
| CARA Cara Therapeutics, Inc. | S Sale | 2020-11-17 | 2020-11-19 | 6,000 | $16.09 | $96.5K | 14,400 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 21,600 | — | $0 | 21,600 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award | 2020-06-04 | 2020-06-08 | 14,400 | — | $0 | 20,400 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award | 2019-06-04 | 2019-07-01 | 6,000 | — | $0 | 6,000 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2019-06-04 | 2019-06-06 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award | 2019-06-04 | 2019-06-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2018-06-06 | 2018-06-08 | 18,000 | — | $0 | 18,000 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2017-06-21 | 2017-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2016-06-15 | 2016-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2016-03-17 | 2016-03-18 | 247,727 | $4.93 | $1.22M | 3,068,057 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2016-03-16 | 2016-03-18 | 152,273 | $4.78 | $727.9K | 2,820,330 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | A Award deriv | 2015-06-24 | 2015-06-26 | 12,000 | $5.03 | $60.4K | 21,857 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2015-06-08 | 2015-06-10 | 13,500 | — | $0 | 13,500 | SEC↗ |
| NRX NephroGenex, Inc. | A Award deriv | 2014-05-15 | 2014-05-16 | 3,076 | — | $0 | 3,076 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 1,215,268 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 106,697 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 106,697 | — | $0 | 106,697 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 1,215,268 | — | $0 | 1,215,268 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 106,697 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 1,215,268 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 494,447 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 5,631,531 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | A Award | 2014-02-14 | 2014-02-19 | 180,997 | — | $0 | 1,326,826 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion | 2014-02-14 | 2014-02-19 | 203,374 | — | $0 | 1,145,829 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion | 2014-02-14 | 2014-02-19 | 942,455 | — | $0 | 942,455 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 6,105,598 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2014-02-05 | 2014-02-05 | 225,818 | $11.00 | $2.48M | 2,668,057 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 2,442,239 | — | $0 | 2,442,239 | SEC↗ |
| CARA Cara Therapeutics, Inc. | A Award deriv | 2014-01-30 | 2014-01-31 | 20,000 | — | $0 | 20,000 | SEC↗ |